Clinical ResearchRescheduling Will Reprice Medical IP, Not Retail FootprintsUS cannabis rescheduling is unlikely to trigger a land grab.Stephen Murphy11 March 2026
CultivationFuture-Ready: Why Pure Is Building the Cannabis Company Traditional Industry Will Want to Buy Into5 February 2026
PharmaceuticalNew Era Beckons For Swiss Medical Cannabis Patients After Ten Years In Slow Lane22 June 2021